NEU 0.15% $13.13 neuren pharmaceuticals limited

Share Price, page-3686

  1. 236 Posts.
    lightbulb Created with Sketch. 37


    Here is what Chat GPT (AI) thoughts are on the matter of ROW partner for Trofinetide - Global Pharma with a strong focus on CNS disorders !!

    Noting that #2 has always been a strong pick of Sillazze from memory.

    There are several pharmaceutical companies that specialize in the development of treatments for rare central nervous system (CNS) diseases. Some of these companies include:

    1. UniQure: UniQure is a biopharmaceutical company focused on the development of gene therapies for the treatment of CNS diseases.

    2. Roche: Roche is a multinational pharmaceutical company with a strong presence in the CNS disease space. It has a wide portfolio of innovative treatments for various CNS diseases.

    3. Novartis: Novartis is a multinational pharmaceutical company that has a strong focus on the development of treatments for CNS diseases. It has a wide portfolio of innovative treatments for various CNS diseases.

    4. Biogen: Biogen is a biopharmaceutical company that specializes in the development of treatments for CNS diseases. It has a wide portfolio of innovative treatments for various CNS diseases, including Alzheimer's disease and multiple sclerosis.

    5. Sanofi: Sanofi is a multinational pharmaceutical company that has a strong focus on the development of treatments for CNS diseases. It has a wide portfolio of innovative treatments for various CNS diseases.

    These are just a few examples of pharmaceutical companies that specialize in the development of treatments for CNS diseases. There are many other companies that are committed to finding treatments for these often-challenging and debilitating conditions.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.